Entera Bio Ltd. - Ordinary Shares (ENTX)
1.7960
-0.0190 (-1.05%)
Entera Bio Ltd is a biotechnology company focused on developing innovative oral drug delivery technologies to improve the treatment of various diseases, particularly in the areas of metabolic and endocrine disorders
By leveraging its proprietary platform, the company aims to create oral formulations of biologic drugs, which are traditionally administered via injections. Entera Bio's work includes the advancement of therapies designed to enhance patient compliance and reduce the burden of needle-based treatments, ultimately striving to provide effective and convenient options for those in need of advanced medical care.
Previous Close | 1.815 |
---|---|
Open | 1.800 |
Bid | 1.770 |
Ask | 1.950 |
Day's Range | 1.790 - 1.830 |
52 Week Range | 1.410 - 3.350 |
Volume | 20,300 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 53,046 |
News & Press Releases

ENTX stock results show that Entera Bio met analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 12, 2024

These are the meme stocks to buy as they represent fundamentally strong ideas with major growth acceleration catalysts.
Via InvestorPlace · July 23, 2024

Don't wait too long on these attractive meme stocks to buy for 200% upside, as they represent good businesses with growth catalysts.
Via InvestorPlace · July 8, 2024

These are the clinical-stage biotech stocks to buy, as they represent companies with an attractive product pipeline.
Via InvestorPlace · July 2, 2024

Investors can't miss out on meme stocks to buy on the dip since these represent fundamentally sound ideas with growth acceleration catalysts
Via InvestorPlace · June 25, 2024

Wise investors consider penny stocks to buy which represent companies with vigorous fundamentals and a robust growth outlook.
Via InvestorPlace · June 20, 2024

These are the penny stocks to buy, representing businesses with a promising growth outlook for the long term.
Via InvestorPlace · June 20, 2024

These are undervalued penny stocks to buy as they represent companies with the likelihood of multi-fold growth in revenue.
Via InvestorPlace · June 17, 2024

These are the biotech stocks under $10 that are attractively valued and have potential catalysts in the form of positive clinical trials news
Via InvestorPlace · June 10, 2024

These are the biotech stocks to buy for a meme rally as they represent companies with positive impending news related to clinical trials.
Via InvestorPlace · June 7, 2024

These are the biotech stocks to buy for a massive rally in the coming quarters on the back of positive clinical progress.
Via InvestorPlace · May 23, 2024

ENTX stock results show that Entera Bio beat analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 10, 2024

Discover three biotech stocks with explosive growth potential. Don't miss out on these great picks this year.
Via InvestorPlace · April 15, 2024

The Dow Jones index closed slightly higher on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · January 12, 2024

The Dow Jones closed lower by 175 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · August 23, 2023

Gainers
Via Benzinga · March 7, 2023

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the European market.
Via Benzinga · March 7, 2023

Gainers Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares surged 159% to $1.27 after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch Renazorb.
Via Benzinga · March 6, 2023

Gainers Secoo Holding Limited (NASDAQ: SECO) rose 44% to $1.44 in pre-market trading after dipping over 31% on Friday.
Via Benzinga · March 6, 2023

Gainers Elys Game Technology, Corp. (NASDAQ: ELYS) shares rose 63.2% to $0.4201 in pre-market trading after dropping 8% on Tuesday. Elys Game Technology and Cloakbook were recently granted a license to commence sportsbook operations in Washington, D.C.
Via Benzinga · January 4, 2023

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday!
Via InvestorPlace · January 4, 2023

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.
Via Benzinga · November 17, 2022

The Dow Jones gained by over 50 points on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · November 16, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday.
Via Benzinga · November 14, 2022